I agree with the concept that increasing the money income from milk is the key concept and the optimum way is to improve the revenue from cows with sub-clinical mastitis. A vaccine is not a good idea, because it would increase the number of antibodies in the cow, and will lower the value of the milk if given to "healthy" cows.
My idea of treatment can be done with very low cost. Some onr can buy from Walgreens or online a couple of bottles of SinoFresh for about $15 each.
Pick a grouping of about 100 cows whose milk output can be can be separated from the rest of the herd so its value can be determined and its value measured.
I would run this test about 3 months My concept is that the group of cows
would have their noses sprayed twice a week for about three months. Ideally, the group would be compared with a "control" grup of a simulat nomber of cows that did not get the spray
This is certainly not a "clinical trial" No FDA involvement at all. I think it is quite legal. The farme will have an idea of how much additional income he can get by using the procedure.
I think it will be far about the cost of producing the few ounces of drug used in the process
Norman
Recent ICCC News
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 2024 • GlobeNewswire Inc. • 04/09/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 06:55:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/27/2024 09:05:32 PM
- ImmuCell Announces Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 • GlobeNewswire Inc. • 02/27/2024 09:05:00 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter and Year Ended December 31, 2023 • GlobeNewswire Inc. • 02/16/2024 02:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:05:32 PM
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 2023 • GlobeNewswire Inc. • 01/08/2024 09:05:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 08:22:13 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:05:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 09:05:46 PM
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 11/13/2023 09:05:00 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended September 30, 2023 • GlobeNewswire Inc. • 11/07/2023 05:15:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 08:05:21 PM
- ImmuCell Announces Preliminary, Unaudited Sales Results for Q3 2023 • GlobeNewswire Inc. • 10/05/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/06/2023 04:25:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/30/2023 06:49:33 PM
- ImmuCell Announces Submission of CMC Technical Section to the FDA • GlobeNewswire Inc. • 08/29/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/10/2023 08:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/10/2023 08:05:44 PM
- ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2023 • GlobeNewswire Inc. • 08/10/2023 08:05:00 PM
- ImmuCell to Announce Unaudited Financial Results for the Quarter Ended June 30, 2023 • GlobeNewswire Inc. • 08/07/2023 04:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/21/2023 01:04:28 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 07/13/2023 06:28:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 08:05:21 PM
VPR Brands LP Reports Record Annual Financial Performance for Fiscal Year 2023 • VPRB • Apr 19, 2024 11:24 AM
Coinllectibles' Subsidiary, Grand Town Development Limited, Acquires Rare Song Dynasty Ceramics Worth Over USD28million • COSG • Apr 18, 2024 8:03 AM
ILUS Provides Form 10-K Filing Update • ILUS • Apr 17, 2024 9:54 AM
Glucotrack Announces Expansion of Its Continuous Glucose Monitoring Technology to Epidural Glucose Monitoring • GCTK • Apr 17, 2024 8:00 AM
Maybacks Global Entertainment To Fire Up 24 New Stations in Louisiana • AHRO • Apr 16, 2024 1:30 PM
Cannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix • BLOZF • Apr 16, 2024 8:52 AM